Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials

Published:2023-02-25 Issue:1 Volume:18 Page:
ISSN:1862-3514
Container-title:Archives of Osteoporosis
language:en
Short-container-title:Arch Osteoporos

Author:

Li Xiao,Han Jingru,Shi Xiaotong,Bi Zhiguo,Liu Jianguo

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11657-023-01227-9.pdf

Reference40 articles.

1. Peitgen DS, Innmann MM, Merle C, Gotterbarm T, Moradi B, Streit MR (2018) Periprosthetic bone mineral density around uncemented titanium stems in the second and third decade after total hip arthroplasty: a DXA study after 12, 17 and 21 years. Calcif Tissue Int 103(4):372–379. https://doi.org/10.1007/s00223-018-0438-9

2. Nam D, Barrack RL, Clohisy JC, Nunley RM (2016) Proximal femur bone density decreases up to 5 years after total hip arthroplasty in young, active patients. J Arthroplasty 31(12):2825–2830. https://doi.org/10.1016/j.arth.2016.05.059

3. Ulrich SD, Seyler TM, Bennett D, Delanois RE, Saleh KJ, Thongtrangan I, Kuskowski M, Cheng EY, Sharkey PF, Parvizi J, Stiehl JB, Mont MA (2008) Total hip arthroplasties: what are the reasons for revision? Int Orthop 32(5):597–604. https://doi.org/10.1007/s00264-007-0364-3

4. Tyson Y, Rolfson O, Kärrholm J, Hailer NP, Mohaddes M (2019) Uncemented or cemented revision stems? Analysis of 2,296 first-time hip revision arthroplasties performed due to aseptic loosening, reported to the Swedish Hip Arthroplasty Register. Acta Orthop 90(5):421–426. https://doi.org/10.1080/17453674.2019.1624336

5. Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP (2006) The central role of wear debris in periprosthetic osteolysis. HSS J 2(2):102–13. https://doi.org/10.1007/s11420-006-9003-6

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the Efficacy of Antiosteoporotic Drugs in Preventing Periprosthetic Bone Loss Following Total Hip Arthroplasty: A Systematic Review and Bayesian Network Meta‐Analysis;Orthopaedic Surgery;2024-07-26

2. Repurposing anti-osteoporosis drugs for autoimmune diseases: A two-sample Mendelian randomization study;Heliyon;2024-07

3. Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond;Balneo and PRM Research Journal;2024-06-21